http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111084836-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate | 2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111084836-B |
| titleOfInvention | Application of combination of thermionic acid and antibiotics in intervention of antibacterial action against pathogenic bacteria |
| abstract | The invention relates to an application of a combination of a pyrexinin and an antibiotic in intervening the antibacterial action against pathogenic bacteria, which overcomes the problems of drug resistance and poor effect caused by the single use of a traditional Chinese medicine preparation and the antibiotic. The technical scheme adopted by the invention is as follows: an application of the medicine "Reyanning" in preparing the medicines for preventing and treating the pathogenic bacteria of staphylococcus aureus, which contains the mixture of Reyanning, cefoxitin or linezolid as antibiotic and methicillin-resistant staphylococcus aureus as pathogenic bacteria. The dilution multiple of the antipyretic for treating the fever is 1:8, and the minimum bacteriostatic concentration of the combination of the two medicines is when the concentration of the cefoxitin is 4 mg/ml; the combination of 1/8MIC therminin and 1/2MIC linezolid has stronger bacteriostatic effect than each single drug. |
| priorityDate | 2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.